JPRN-UMIN000038507尚未招募未知
11C-preladenant imaging in Parkinson's disease - 11C-preladenant imaging in Parkinson's disease
Tokyo Metropolitan Institute of Gerontology0 个研究点目标入组 20 人开始时间: 2019年12月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The subjects who cannot undergo MRI. The subject who have chronic dysfunction in the organs. Pregnant or woman who has a chance of pregnant. The subjects who were judged by the clinical investigator to be inappropriate as a participant in this study.
研究者
相似试验
撤回
不适用
The role of imaging in Parkinson*s disease subtypes: a pilot study .NL-OMON35081eids Universitair Medisch Centrum10
已完成
不适用
Imaging Biomarkers in Parkinson s DiseaseParkinson DiseaseNCT01496599National Institute of Neurological Disorders and Stroke (NINDS)62
撤回
不适用
Molecular and Functional Imaging in SNCA, Parkin and PINK1PARK1PARK2Parkinson DiseaseNCT04084509King's College London
已完成
不适用
In vivo imaging of neuroinflammation in Parkinson's disease: A first in human purinergic P2X7 receptor PET study <br>Parkinson's diseaseNL-OMON44519Vrije Universiteit Medisch Centrum14
进行中（未招募）
1 期
Parkinson’s Disease: PET scan and evaluation of memantines pharmacological effect.(Parkinsons sygdom bedømt med PET skanning, herunder memantins farmakologiske effekt.) - N/AParkinson's DiseaseEUCTR2004-004139-74-DKeurologisk afdeling F12